Financial Data and Key Metrics Changes - First quarter 2023 revenues reached 806.7million,anincreaseof83.1 million or 11.5% year-over-year, with a 13.8% increase when excluding the estimated negative impact of foreign exchange [12][78] - Earnings per share (EPS) were 1.34,downfrom1.66 in the prior year quarter [12] - Adjusted EBITDA for the first quarter 2023 was 78.4million,adecreaseof13.390.5 million in the prior year quarter [68] Business Line Data and Key Metrics Changes - Corporate Finance & Restructuring revenues were 300million,up18.4169.6 million, primarily due to higher demand for M&A-related antitrust services [87] - Forensic and Litigation Consulting (FLC) revenues rose 12.7% to 173.4million,attributedtoincreaseddemandfordataandanalytics,investigations,andhealthsolutionsservices[69]MarketDataandKeyMetricsChanges−Restructuringrevenuesgrew3817.8 million worth of shares during the quarter, with approximately 460.7millionremainingforfuturebuybacks[89]−Totaldebtnetofcashincreasedto122.7 million as of March 31, 2023, compared to $60.1 million a year earlier [89] Q&A Session Summary Question: What is the outlook for restructuring activity? - Management noted a sequential increase in restructuring revenues, indicating strength in both the U.S. and overseas markets [92] Question: Were there any significant timing items affecting revenue? - Management acknowledged revenue deferrals and other factors like FX and bad debt that can impact quarterly results [93] Question: How does the company view the hiring opportunities in the current market? - Management highlighted robust hiring, particularly outside the U.S., driven by the company's improved reputation and ability to attract top talent [97]